The Hirshberg Foundation is happy to announce that Dr. Timothy Donahue will be joining us at the 16th Annual Symposium on Pancreatic Cancer to highlight the exciting collaboration efforts of the UC Pancreatic Cancer Consortium.
“The mission of the UC Pancreatic Cancer Consortium (UCPCC) is to unite scientists and clinicians across the UC cancer centers committed to pancreatic cancer research and treatment in a highly collaborative environment that accelerates the progress and impact of our work. Our vision is to improve the lives of persons diagnosed with pancreatic cancer by translating innovative research into improved clinical care.” The five cancer centers include UC Davis Comprehensive Cancer Center, UC Irvine Chao Family Comprehensive Cancer Center, UCLA Jonsson Comprehensive Cancer Center, UC San Diego Moores Cancer Center and UC San Francisco Helen Diller Family Comprehensive Cancer Center.
Dr. Timothy Donahue is Chief of the Division of Surgical Oncology and Professor of Surgery at the David Geffen School of Medicine at UCLA. He also has a joint appointment in the Department of Molecular and Medical Pharmacology to facilitate his research program. Dr. Donahue is the Surgical Director of the UCLA Agi Hirshberg Center for Pancreatic Diseases. He is a very busy pancreatic surgeon and performs three to four pancreatic surgeries per week. He is genuinely interested in caring for patients with pancreatic cancer and making sure they receive state-of-the-art care. In addition to his clinical work, Dr. Donahue is the Principal Investigator of a National Institutes of Health funded research laboratory. His scientific research focuses on developing new drugs and better treatment strategies for patients with pancreatic cancer, collaborating with numerous other researchers across the UCLA campus. He is also dedicated to training the next generation of academic surgeons and serves as the Program Director of the UCLA General Surgery Residency.
Collaboration is the key to improving patient outcomes, and ultimately finding a cure for pancreatic cancer. Dr. Donahue is no stranger to collaboration and we are excited to hear from him on what the future holds with his presentation, UC Pancreatic Cancer Consortium: Collaboration at Work.
